LAFAYETTE, La., April 11, 2023 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD and TSX:VMD.TO), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it will present at the 2023 Bloom Burton & Co. Healthcare Investor Conference on Wednesday, April 26, 2023 at 2:30 PM ET in Toronto, Ontario at the Metro Toronto Convention Centre.
The Bloom Burton & Co. Healthcare Investor Conference brings together U.S., Canadian and international investors interested in the latest developments in the Canadian healthcare sector. Attendees will have an opportunity to obtain corporate updates from the premier Canadian publicly traded and private companies through presentations and private meetings. The 2023 conference will take place at the Metro Toronto Convention Centre in Toronto, Ontario on April 25th and 26th. To register for the conference, please visit the following link: https://www.meetmax.com/sched/event_91703/conference_register.html
During the conference, Casey Hoyt, CEO, and Todd Zehnder, COO, will conduct an introductory presentation that will cover key areas of the Viemed business. Additionally, investors that are registered at the conference will have the ability to request one-on-one meetings with management.
The presentation webcast and presentation slides will be available live and can be accessed through the following link: https://wsw.com/webcast/bloomburton8/vmd.to/3108072
Following the event, a replay of the presentation will remain available for 90 days.
ABOUT VIEMED HEALTHCARE, INC.
Viemed is a provider of in-home medical equipment and post-acute respiratory healthcare services in the United States. Viemed’s service offerings are focused on effective in-home treatment with clinical practitioners providing therapy and counseling to patients in their homes using cutting-edge technology. Visit our website at www.viemed.com.
For further information, please contact:
Glen Akselrod
Bristol Capital
905-326-1888
This email address is being protected from spambots. You need JavaScript enabled to view it.
Todd Zehnder
Chief Operating Officer
Viemed Healthcare, Inc.
337-504-3802
This email address is being protected from spambots. You need JavaScript enabled to view it.
Last Trade: | US$6.61 |
Daily Change: | -0.27 -3.92 |
Daily Volume: | 197,980 |
Market Cap: | US$257.390M |
March 10, 2025 November 06, 2024 April 02, 2024 |
Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....
CLICK TO LEARN MOREClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MOREEnd of content
No more pages to load